REKEMEND Trademark

Trademark Overview


On Tuesday, March 23, 2021, a trademark application was filed for REKEMEND with the United States Patent and Trademark Office. The USPTO has given the REKEMEND trademark a serial number of 90596028. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Thursday, August 1, 2024. This trademark is owned by 1295286 B.C. LTD.. The REKEMEND trademark is filed in the Pharmaceutical Products category with the following description:

Appetite suppressant pills; Appetite suppressants; Appetite suppressants for medical purposes; Fungal extracts sold as a component ingredient of nutritional supplements and vitamins; Fungal medications; Nutraceuticals for use as a dietary supplement; Pharmaceutical preparations for the treatment of hypercholesteremia; Pharmaceutical preparations for the treatment of hyperlipidemia; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of cancer; Pharmaceutical skin lotions; Pharmaceuticals, namely, lipid lowering agents; Pharmaceuticals, namely, psychotropics; Balms for pharmaceutical purposes; Dietary supplement beverage for supporting immunity, enhancing mood and well-being, and suppressing appetite; Dietary supplement drink mix...
rekemend

General Information


Serial Number90596028
Word MarkREKEMEND
Filing DateTuesday, March 23, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateThursday, August 1, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 7, 2021

Trademark Statements


Goods and ServicesAppetite suppressant pills; Appetite suppressants; Appetite suppressants for medical purposes; Fungal extracts sold as a component ingredient of nutritional supplements and vitamins; Fungal medications; Nutraceuticals for use as a dietary supplement; Pharmaceutical preparations for the treatment of hypercholesteremia; Pharmaceutical preparations for the treatment of hyperlipidemia; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of cancer; Pharmaceutical skin lotions; Pharmaceuticals, namely, lipid lowering agents; Pharmaceuticals, namely, psychotropics; Balms for pharmaceutical purposes; Dietary supplement beverage for supporting immunity, enhancing mood and well-being, and suppressing appetite; Dietary supplement drink mixes; Dietary supplements; Dietary supplements also containing adaptogens, nootropics, mushrooms and mushroom extracts; Dietary supplements consisting primarily of adaptogens, nootropics, mushrooms and mushroom extracts; Dietary supplements for controlling cholesterol; Dietary supplements for human consumption; Dietary and nutritional supplements; Dietary and nutritional supplements containing adaptogens, nootropics, mushrooms and mushroom extracts; Dietary and nutritional supplements for endurance sports; Dietary and nutritional supplements for supporting immunity, enhancing mood and well-being, and suppressing appetite; Dietary and nutritional supplements used for weight loss; Dietary beverage supplements for human consumption in liquid and dry mix form for therapeutic purposes; Dietary food supplements; Dietary supplements in the nature of weight loss powders; Dietetic preparations adapted for medical purposes; Flour for pharmaceutical purposes; Food supplements; Health food supplements; Homeopathic supplements; Liquid nutritional supplement; Natural supplements for treating depression and anxiety; Natural dietary supplements; Nutraceuticals for use as a dietary supplement for supporting immunity, enhancing mood and well-being, and suppressing appetite; Nutritional supplement shakes; Nutritional supplements; Nutritional supplements consisting primarily of adaptogens, nootropics, mushrooms and mushroom extracts; Pharmaceutical preparations, namely, appetite suppressants; Powdered nutritional supplement concentrate; Powdered nutritional supplement drink mix; Powdered nutritional supplement drink mix and concentrate; Therapeutic agents for weight control and appetite suppression; Weight management supplements

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, June 26, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameREKEMEND LLC
Party Type21 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressHOLLYWOOD, FL 33019

Party Name1295286 B.C. LTD.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressToronto M5A1N1
CA

Party Name1295286 B.C. LTD.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressToronto M5A1N1
CA

Trademark Events


Event DateEvent Description
Friday, March 26, 2021NEW APPLICATION ENTERED
Saturday, June 26, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 28, 2021ASSIGNED TO EXAMINER
Friday, October 29, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 12, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, November 17, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 7, 2021PUBLISHED FOR OPPOSITION
Tuesday, December 7, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 1, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, August 1, 2022SOU EXTENSION 1 FILED
Monday, August 1, 2022SOU TEAS EXTENSION RECEIVED
Monday, August 1, 2022SOU EXTENSION 1 GRANTED
Friday, February 3, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 1, 2023SOU EXTENSION 3 FILED
Wednesday, August 3, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 1, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, February 1, 2023SOU EXTENSION 2 FILED
Wednesday, February 1, 2023SOU EXTENSION 2 GRANTED
Tuesday, August 1, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, August 1, 2023SOU EXTENSION 3 GRANTED
Thursday, August 3, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 1, 2024SOU EXTENSION 4 FILED
Thursday, February 1, 2024SOU EXTENSION 4 GRANTED
Saturday, February 3, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 1, 2024SOU TEAS EXTENSION RECEIVED
Thursday, August 1, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 1, 2024SOU EXTENSION 5 FILED
Thursday, August 1, 2024SOU EXTENSION 5 GRANTED
Thursday, February 1, 2024SOU TEAS EXTENSION RECEIVED